• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS/ RESPIRONICS, INC. RESPIRINONICS DREAM CPAP MACHINE; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS/ RESPIRONICS, INC. RESPIRINONICS DREAM CPAP MACHINE; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problem Unexpected Therapeutic Results (1631)
Patient Problem Cough (4457)
Event Date 02/01/2022
Event Type  Injury  
Event Description
Severe cough, urgent care visits, several medications, chest x-ray, chest ct scan, dr visits, ent visit, continued severe coughing.Fda safety report id #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESPIRINONICS DREAM CPAP MACHINE
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS/ RESPIRONICS, INC.
MDR Report Key14513861
MDR Text Key292816685
Report NumberMW5109921
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/25/2022
Patient Sequence Number1
Treatment
ATORVASTATIN; LOSARTAN ; METOPROLOL ; XARELTO
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient SexMale
Patient Weight104 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-